Literature DB >> 35382364

Response to: Comment on "The evaluation of nailfold capillaroscopy pattern in patients with fibromyalgia''.

İlke Coşkun Benlidayı1, Esra Kayacan Erdoğan2, Aylin Sarıyıldız3.   

Abstract

Entities:  

Year:  2021        PMID: 35382364      PMCID: PMC8957760          DOI: 10.46497/ArchRheumatol.2021.8933

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


× No keyword cloud information.
We deeply thank to Dr. Lambova for her appreciable point of view and comments on our recent article entitled “The Evaluation of Nailfold Capillaroscopy Pattern in Patients With Fibromyalgia”. The results of our study revealed a significantly higher mean capillary loop diameter, higher number of avascular areas, micro-aneurysms, and neoangiogenic capillaries in patients with fibromyalgia, compared to healthy controls.[1] On the other hand, none of the patients reported symptoms of Raynaud’s phenomenon. However, patients with certain findings in capillaroscopy could be candidates of future Raynaud’s phenomenon/disease. It is well-accepted that abnormal capillaroscopic findings such as micro-aneurysms, avascular areas, and neoangiogenic capillaries are not expected in primary Raynaud’s phenomenon, that is to say, Raynaud’s disease. Nevertheless, primary Raynaud’s phenomenon may transit to secondary Raynaud’s phenomenon, and an abnormal nailfold capillaroscopy pattern is regarded as the best predictor of this transition.[2,3] In a prospective study by Hirschl et al.,[4] the annual incidence of transition to suspected secondary Raynaud’s phenomenon and secondary Raynaud’s phenomenon was found to be 2% and 1%, respectively. On a different point of view, concomitant fibromyalgia is a frequent comorbidity in patients with autoimmune and inflammatory rheumatic diseases.[5,6] In this regard, it is also likely that these patients, particularly those with abnormal capillaroscopic findings, present with signs/ symptoms of autoimmune and inflammatory rheumatic diseases in the future. Generalized pain may be the early symptom of an autoimmune inflammatory rheumatic disease among this particular subgroup of patients. In the light of this hypothesis, it is of worthy to follow the patients with abnormal capillaroscopic findings for autoimmune inflammatory rheumatic diseases. Abnormal capillaroscopic findings among a certain number of patients with fibromyalgia may be related to the potential role of inflammation in fibromyalgia etiopathogenesis.[7] Further research would be of value to clarify this hypothetic consideration. Moreover, the findings of our study highlight the need for observing these patients for the development of possible primary or secondary Raynaud phenomenon. In this regard, regular clinical observation of these individuals, along with laboratory examination when necessary, would be of paramount importance.
  7 in total

1.  Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.

Authors:  Mirko Hirschl; Katharina Hirschl; Matthias Lenz; Reinhold Katzenschlager; Hans-Peter Hutter; Michael Kundi
Journal:  Arthritis Rheum       Date:  2006-06

Review 2.  Role of inflammation in the pathogenesis and treatment of fibromyalgia.

Authors:  Ilke Coskun Benlidayi
Journal:  Rheumatol Int       Date:  2019-02-13       Impact factor: 2.631

3.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases.

Authors:  G Spencer-Green
Journal:  Arch Intern Med       Date:  1998-03-23

4.  Prospective capillaroscopy-based study on transition from primary to secondary Raynaud's phenomenon: preliminary results.

Authors:  E Bernero; A Sulli; G Ferrari; F Ravera; C Pizzorni; B Ruaro; G Zampogna; E Alessandri; M Cutolo
Journal:  Reumatismo       Date:  2013-10-31

Review 5.  The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management.

Authors:  Camillo Giacomelli; Rosaria Talarico; Stefano Bombardieri; Laura Bazzichi
Journal:  Expert Rev Clin Immunol       Date:  2013-11       Impact factor: 4.473

Review 6.  Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases.

Authors:  Ilke Coskun Benlidayi
Journal:  Rheumatol Int       Date:  2020-01-03       Impact factor: 2.631

7.  The evaluation of nailfold capillaroscopy pattern in patients with fibromyalgia.

Authors:  İlke Coşkun Benlidayı; Esra Kayacan Erdoğan; Aylin Sarıyıldız
Journal:  Arch Rheumatol       Date:  2021-01-15       Impact factor: 1.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.